# A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

> **NCT05437211** · NA · COMPLETED · sponsor: **Takeda** · enrollment: 24 (actual)

## Conditions studied

- Hemophilia

## Interventions

- **DEVICE:** Virtual-reality (VR) Based Solution

## Key facts

- **NCT ID:** NCT05437211
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-23
- **Primary completion:** 2024-02-21
- **Final completion:** 2024-02-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05437211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05437211, "A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05437211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*